| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/27/1999 | US5929224 Dna encoding human white blood cell activating proteins; useful in diagnosis as anticarcinogenic agents |
| 07/27/1999 | US5929223 Nucleotide sequence of drosophila cyclic 3',5'-adenosine monophosphate responsive transcriptional activator and antagonist |
| 07/27/1999 | US5929222 Expression of a foamy virus envelope protein |
| 07/27/1999 | US5929220 Hepadnavirus receptor |
| 07/27/1999 | US5929213 Antibodies to growth differentiation factor-12 |
| 07/27/1999 | US5929212 CD3 specific recombinant antibody |
| 07/27/1999 | US5929210 Purified polypeptide of irreversible, extracellular serine protease inhibitor; for diagnosis/treatment of related diseases; antitumor agents; cushing's/alzheimer's/parkinson's diseases; dwarfism; eating disorders |
| 07/27/1999 | US5929114 Administering antiviral compound which extrudes zinc from nucleocapsid protein of human immunodeficiency virus |
| 07/27/1999 | US5929055 Tetracycline |
| 07/27/1999 | US5929048 Treatment of conditions and disease |
| 07/27/1999 | US5929045 Screening for bactericides |
| 07/27/1999 | US5929043 Inhibiting copying of dna at target sequence in viable cell by introducing into said cell a pair of nucleoprotein filaments, where the filaments each comprise a ssdna strand coated with a recombinase, forming double d-loop |
| 07/27/1999 | US5929042 Antisense compounds which prevent cell death and uses thereof |
| 07/27/1999 | US5929041 Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product |
| 07/27/1999 | US5929040 Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 07/27/1999 | US5929039 Method for treating cardiac dysfunction and pharmaceutical compositions useful therefor |
| 07/27/1999 | US5929036 Ligand or GMP-140 selectin and methods of use thereof |
| 07/27/1999 | US5929035 Methods of treating intestinal disorders |
| 07/27/1999 | US5929034 Use of α-conotoxin MII to treat disorders resulting from nicotine-stimulated dopamine release |
| 07/27/1999 | US5929033 Therapy for infection, gastrointestinal disorders, cancer |
| 07/27/1999 | US5929032 Method for treating Schwann and colon cells in vitro |
| 07/27/1999 | US5929031 Storage stable hemoglobin solutions |
| 07/27/1999 | US5929030 Pharmaceutical compositions |
| 07/27/1999 | US5929029 Human calcium-binding phosphoprotein |
| 07/27/1999 | US5929028 Liquid gonadotropin containing formulations |
| 07/27/1999 | US5929027 Physiologically active polypeptide-containing pharmaceutical composition |
| 07/27/1999 | US5928942 Hormone-secreting cells derived from pancreatic islet maintained in long-term culture |
| 07/27/1999 | US5928940 Morphogen-responsive signal transducer and methods of use thereof |
| 07/27/1999 | US5928939 Genetic engineering |
| 07/27/1999 | US5928938 Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof |
| 07/27/1999 | US5928931 Antiproliferative/antitumor/anticarcinogenic agents; immunosuppressants |
| 07/27/1999 | US5928928 For diagnosis of infections; for fungicides, antiprotozoa agents, antihelminthic agents; in body lotions, dentrifices, foods; for temporary implants; time-release agents |
| 07/27/1999 | US5928926 Isolation and cloning of the human ARSA-I gene and uses thereof |
| 07/27/1999 | US5928924 A isolate polypeptide encoded by genetic engineered hybridized polynucleotide for controlling morphology of cells; antagonist against such polypeptides and their use as a therapeutic to treat cancer |
| 07/27/1999 | US5928923 Polynucleotides |
| 07/27/1999 | US5928921 Nucleotide sequence of enzyme which oxidizes xenobiotics; for evaluating human xenobiotic metabolism in vitro |
| 07/27/1999 | US5928920 Amino acid sequence of enzyme which catalyzes addition of threonyl to transfer ribonucleic acid; for bacteristats and bactericides |
| 07/27/1999 | US5928915 Nucleotide sequences that codes for a cytosolic enzyme from chinese hamster ovaries; diagnosis, antiflammatory agents; antiarthritic agents, antitubercular agents, and viricides |
| 07/27/1999 | US5928904 Nucleic acids which code for immunoglobulin heavy chain complementarity determining region; for antibodies against interleukin 4 for treatment or diagnosis of allergies |
| 07/27/1999 | US5928900 Amino acid sequences from streptococcus pneumoniae |
| 07/27/1999 | US5928899 Cell division regulators |
| 07/27/1999 | US5928898 Multiple drug resistance gene atrD of Aspergillus nidulans |
| 07/27/1999 | US5928896 Genetically engineering a polypeptide that mimics sweet or taste modifier peptide; different length but contains interaction site flanked by prolines |
| 07/27/1999 | US5928895 IgA Fc binding protein |
| 07/27/1999 | US5928894 Diagnosis, prevention and therapy for infection, immunology and neoplastic disorders |
| 07/27/1999 | US5928893 Monoclonal antibody specific for human 4-1BB and cell line producing same |
| 07/27/1999 | US5928885 Includes one detectable antibody against 80 kilodalton form of calcium-activated neutral proteinase, another detectable antibody against other isoforms, standard serial dilutions of proteinase isoforms for standard curve |
| 07/27/1999 | US5928884 FHIT proteins and nucleic acids and methods based thereon |
| 07/27/1999 | US5928882 Treatment and prevention of neurodegenerative diseases using modulators of Fe65 |
| 07/27/1999 | US5928876 Peptide and collagen contraction inhibitor |
| 07/27/1999 | US5928874 Nek1-related protein kinase |
| 07/27/1999 | US5928873 Testing extraintestinal tissues or body fluids for presence of heat stable toxin receptor protein, comparing to negative control assay, increased presence indicates metastasis |
| 07/27/1999 | US5928865 Nucleic acids from region located 5' to cytotoxin associated protein locus; for diagnosis of gastrointestinal disorders associated with this bacteria; vaccines; antiulcer agents |
| 07/27/1999 | US5928861 Using specific antibodies against an epitope in the envelope protein gp46 for the detection of human t-cell leukemia virus in humans |
| 07/27/1999 | US5928670 Method of inhibiting aldose reductase in vivo with intrinsic inhibitors of aldose reductase |
| 07/27/1999 | US5928650 Preventing bacterial meningitis caused by serogroup b using anon-polysaccharide |
| 07/27/1999 | US5928649 Administering interleukin or inducer concurrently with vaccine to swine or cattle |
| 07/27/1999 | US5928645 Extract containing berberine and a flavonoid |
| 07/27/1999 | US5928643 Gene expression; medical diagnosis |
| 07/27/1999 | US5928641 Having binding specificity for crossreactive epitopes shared by endoglin expressed on human vascular endothelial cells and endoglin expressed on murine vascular endothelial cells |
| 07/27/1999 | US5928640 Administering a protease to human or animal patient to inhibit increased intenstinal fluid seceretion induced by non-bacterial secretagogue |
| 07/27/1999 | US5928639 Immunotherapy of cancer with allogeneic lymphocytes |
| 07/27/1999 | US5928636 Injecting synergistic mixture to treat herpes, hepatitis, papilloma and human t-cell leukemia/lymphoma viruses; administering as bactericide, parasiticide, and/or antiprotozoa agent |
| 07/27/1999 | US5928624 Compositions for neutralization of lipopolysaccharides |
| 07/27/1999 | US5928469 Process for storage of materials |
| 07/27/1999 | US5927230 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/27/1999 | CA1340684C Antiherpes pentapeptides |
| 07/27/1999 | CA1340683C Antiherpes pentapeptides having a substituted aspartic acid side chain |
| 07/27/1999 | CA1340682C Antiviral peptides having a 2-oxoalkyl amino acid side chain |
| 07/27/1999 | CA1340681C Antiherpes tetrapeptides having a substituted aspartic acid side chain |
| 07/26/1999 | CA2220854A1 Anti-ulcer composition |
| 07/22/1999 | WO1999036570A2 Transglutaminase linkage of agents to tissue |
| 07/22/1999 | WO1999036566A1 Mmsc1 - an mmac1 interacting protein |
| 07/22/1999 | WO1999036565A1 Human ependymin |
| 07/22/1999 | WO1999036562A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | WO1999036552A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 07/22/1999 | WO1999036550A2 Human protease molecules |
| 07/22/1999 | WO1999036548A1 Human lymphoid protein tyrosine phosphatases |
| 07/22/1999 | WO1999036545A2 Adenoviral vectors with modified capsid proteins |
| 07/22/1999 | WO1999036544A2 Neisseria meningitidis antigens |
| 07/22/1999 | WO1999036541A1 INTERLEUKIN-1 RECEPTOR ANTAGONIST BETA (IL-1RAβ) |
| 07/22/1999 | WO1999036540A1 Human chemokine and its use for detection and treatment of breast disease |
| 07/22/1999 | WO1999036538A1 Enhancement of cardiac chronotropy |
| 07/22/1999 | WO1999036536A2 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system |
| 07/22/1999 | WO1999036535A1 Apo-2 ligand |
| 07/22/1999 | WO1999036534A1 CLONING AND CHARACTERIZATION OF A cdc 15-LIKE ADAPTOR PROTEIN (CD2BP1) |
| 07/22/1999 | WO1999036533A2 Nucleic acid corresponding to mutation associated with cholestasis syndromes |
| 07/22/1999 | WO1999036530A2 Lh-receptor gene promoter for tissue-specific gene expression |
| 07/22/1999 | WO1999036529A2 Twik-1 related two p domains potassium channel |
| 07/22/1999 | WO1999036524A1 Cbmaae03: a gene similar to ribosomal protein l33 |
| 07/22/1999 | WO1999036523A1 A gene similar to rat golgi v-snare (gos-28) (cblalg01) |
| 07/22/1999 | WO1999036522A1 A gene having low similarity to tropomyosin (cbcadb07) |
| 07/22/1999 | WO1999036518A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4 |
| 07/22/1999 | WO1999036517A2 Method for selecting ribozymes which are capable of covalently modifying the ribonucleic acids on 2'-oh-groups in trans |
| 07/22/1999 | WO1999036514A1 Methods and compositions for gene delivery |
| 07/22/1999 | WO1999036512A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | WO1999036508A1 Histidine kinase |
| 07/22/1999 | WO1999036441A2 Haemopoietic stem cell inhibitor(s) |
| 07/22/1999 | WO1999036440A2 Expression of fusion proteins |
| 07/22/1999 | WO1999036439A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |